2009
Click on the titles to download the press release in pdf format.
- September 1 Cardiome Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer
- August 28 Cardiome Cardiome Announces Upcoming Presentation of Results of Phase 2b Clinical Trial of Vernakalant (oral) at the European Society of Cardiology Congress 2009
- August 25 Cardiome Cardiome Pharma Corp. Announces Tender Offer to Purchase Up To US$27.5 Million Of Its Common Shares
- August 28 CTCS - News For BC Technology Companies Details on this one-day bootcamp-style program that will feature experienced investors from both the Silicon Valley and San Diego markets.
- August 11 Cardiome Cardiome Reports Second Quarter Results/span>
- August 10 Cardiome Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement
- August 10 Cardiome Cardiome to Hold Conference Call
- August 3 Cardiome Cardiome Announces Management Transition
- July 28 Cardiome Cardiome Achieves Milestone From Collaboration With Merck & Co., Inc.
- July 2 Neuromed CombinatoRx and Neuromed Sign Merger Agreement
- June 23 Discovery Parks Vancouver Sun - BC's intellectual capital as a brand identity
- June 17 Neuromed Neuromed Announces Sales of U.S Rights to Drug Candidate Exalgo (hydromorphone HCI) Extended-Release Tablets (CII) to Mallinckrodt
- June 11 Neuromed Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
- May 19 Cardiome Cardiome Announces That Collaboration and License Agreement With Merck & Co., Inc. Now Effective
- May 15 Cardiome Cardiome Reports First Quarter Results
- April 8 Cardiome Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant, an Investigational Drug for Treatment of AtrialFibrillation
- April 8 Cardiome Cardiome to Hold Conference Call
- March 30 Cardiome Cardiome Reports 2008 Results
- February 26 bctia Building for growth
- February 19 bctia BC tech park sparks
- February 14 Discovery Parks From Green to Gold
- January 20 Amorfix Life Sciences Amorfix Awarded "Life Science Company of the Year" for Moving Innovative Products into Commercialization
- January 15 QLT Inc. QLT announces new expiration date of tender offer
- January 13 Amorfix Life Sciences Large-Scale Testing Initiated in France with 10,000 Blood Samples Tested for vCJD
- January 12 QLT Inc. QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation
- January 12 QLT Inc. QLT announces Visudyne(R) sales for fourth quarter and fiscal year 2008